serdolect
pharmacy retailing (nz) ltd t/a healthcare logistics - sertindole 16mg - film coated tablet - 16 mg - active: sertindole 16mg excipient: croscarmellose sodium hyprolose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry pink 03b24027 (rose) - sertindole is indicated for the treatment of schizophrenia. due to cardiovascular safety concerns, sertindole should only be used for patients intolerant to at least one other antipsychotic agent. sertindole should not be used in emergency situations for urgent relief of symptoms in acutely disturbed patients.
serdolect
pharmacy retailing (nz) ltd t/a healthcare logistics - sertindole 20mg - film coated tablet - 20 mg - active: sertindole 20mg excipient: croscarmellose sodium hyprolose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry pink 03b24282 - sertindole is indicated for the treatment of schizophrenia. due to cardiovascular safety concerns, sertindole should only be used for patients intolerant to at least one other antipsychotic agent. sertindole should not be used in emergency situations for urgent relief of symptoms in acutely disturbed patients.
serdolect
pharmacy retailing (nz) ltd t/a healthcare logistics - sertindole 4mg - film coated tablet - 4 mg - active: sertindole 4mg excipient: croscarmellose sodium hyprolose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry yellow 03b22082 - sertindole is indicated for the treatment of schizophrenia. due to cardiovascular safety concerns, sertindole should only be used for patients intolerant to at least one other antipsychotic agent. sertindole should not be used in emergency situations for urgent relief of symptoms in acutely disturbed patients.
mandol cefamandole 500mg (as nafate) powder for injection
aspen pharmacare australia pty ltd - cefamandole, quantity: 500 mg - injection, powder for - excipient ingredients: sodium carbonate - cephamandole nafate is indicated for the treatment of the following infections when sue to susceptible organisms (see pharmacolocy: anti-bacterial activity). (1) respiratory tract infections. (2) genito-urinary tract infections. (3) peritonitis and other intra-abdominal and intra-pelvic infections. (4) septicaemia. (5) skin ans soft-tissue infections. (6) bone and joint infections. note: concentrations of cephamandole in the csf are considerably lower than in the plasma, its use in the treatment of bacterial meningitis and brain abscess is therefore not advised. indications as at 30 june 94: mandol is indicated for the treatment of serious infections of the respiratory tract, genitourinary tract, skin and soft tissue, bones and joints, septicaemia, gall bladder and peritoneum when due to susceptible strains of the above mentioned organisms. concentrations of mandol in the csf are considerably lower than in the plasma; use in the treatment of meningitis and brain abscess is therefore not advised. specimens for
bd vacutainer one use holder
becton dickinson east africa limited, kenya - blood collection tube holder, single use -
fluid delivery mount accessory, holder, infusion pump, multi-outlet
fresenius kabi australia pty ltd - 42498 - fluid delivery mount accessory, holder, infusion pump, multi-outlet - holder, fluid delievery unit
holder, <specify>
b braun australia pty ltd -
37039 - holder,
holder, <specify>
smith & nephew pty ltd -
37039 - holder,
holder, <specify>
ecomed pty ltd -
37039 - holder,
holder, <specify>
bausch & lomb australia pty ltd -
37039 - holder,